Evidence map›Paper›PMID 39770527›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

A Novel In Vivo Method Using

María Pilar de Torre, José Luis Vizmanos, Rita Yolanda Cavero, María Isabel Calvo

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

María Pilar de TorreDepartment of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0002-1112-344X
José Luis VizmanosDepartment of Biochemistry & Genetics, School of Sciences, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0001-7416-3679
Rita Yolanda CaveroDepartment of Environmental Biology, School of Sciences, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0002-8106-3243
María Isabel CalvoDepartment of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0002-3159-0336

Funding

PIUNA Plan Investigador de la Universidad de Navarra, Ref. PIUNA/2018
6 · The paper itself

Abstract

backgroundNon-insulin-dependent diabetes mellitus, or type 2 diabetes, is one of the diseases of greatest concern worldwide, and research into natural compounds that are capable of regulating glycemia and insulin resistance is therefore gaining importance. In the preclinical stages,

methodsWe evaluated the in vitro α-glucosidase inhibition of two oral formulations of

resultsThe crude extract showed a similar IC50 value to that of acarbose (positive control), before and after gastrointestinal digestion. Formulation 1 also showed no differences with the positive control after digestion (111.86 ± 1.26 vs. 110.10 ± 1.00 µL/mL;

conclusionA novel, simple and reliable method has been developed to directly determine pharmacological activities in an in vivo model of wild-type

Indexed as

C. eleganshyperglycemiain vitro digestionO. vulgare

Identifiers

PMID39770527
PMCPMC11677774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.